Genfit
GNFT
GNFT was delisted on the 19th of November, 2025.
6 hedge funds and large institutions have $169K invested in Genfit in 2025 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.02% less ownership
Funds ownership: 0.11% → 0.09% (-0.02%)
17% less capital invested
Capital invested by funds: $203K → $169K (-$33.6K)
25% less funds holding
Funds holding: 8 → 6 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SF
Summit Financial
Parsippany,
New Jersey
|
+$74.4K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$5.43K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$67.9K |
| 2 |
Morgan Stanley
New York
|
-$29K |
| 3 |
Optiver Holding
Amsterdam,
Netherlands
|
-$16.8K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$4 |
GNFT Hedge Fund Activity: Q3 2025 in Review
6 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Genfit (GNFT) for Q3 2025, worth a combined $169K — down 17% from $203K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of GNFT and 1 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was Summit Financial, opening a new position worth an estimated $74.4K. The largest seller was Citadel Advisors, exiting entirely with an estimated $67.9K sold.
- 6 institutional investors held Genfit (GNFT) as of Q3 2025, down from 8 in Q2 2025.
- Funds reported $169K of Genfit stock for Q3 2025, down 17% quarter-over-quarter.
- 1 fund opened new Genfit positions in Q3 2025 and 3 closed out, a net change of -2 holders.
- The largest Genfit buyer in Q3 2025 was Summit Financial, an estimated $74.4K added.
- The largest Genfit seller in Q3 2025 was Citadel Advisors, an estimated $67.9K sold.
Based on aggregated 13F filings for Q3 2025.